Prostate biopsies based on PSA changes are largely unnecessary, researchers say. Feb. 25, 2010— -- If prostate biopsies were based only on the rate of change in PSA level over time, the number of ...
These substantial increases highlight the growing financial burden on patients undergoing necessary diagnostic testing following an abnormal PSA test. Out-of-pocket costs (OOPCs) for diagnostic ...
Despite the common nature of this disease, the United States Preventative Services Task Force (USPSTF) recently published a recommendation that men should not seek PSA testing. Disputes regarding the ...
Despite the improved outcome of radical prostatectomy (RP) in many men with prostate cancer (PCa) in recent years, a number of men still experience prostate-specific antigen (PSA) recurrence and are ...
The Prostate Specific Antigen (PSA) Testing market refers to the sector involved in the development, production, and distribution of diagnostic tests that detect levels of PSA in the blood, a key ...
While a PSA of 12.9 ng/ml does raise concern, it does not automatically mean cancer, noted Dr Saraf. “The risk depends on age ...
According to the latest report by Fact.MR, the global prostate cancer diagnostics market is anticipated to exhibit a steady expansion at 5.3% CAGR during the forecast period 2017 to 2022. In terms of ...
Money raised through past Movember men's health campaigns is helping fund the search for alternatives to PSA screening for prostate cancer. That search has taken on added importance now that an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback